{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:32:13Z","timestamp":1787002333720,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":4699,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1038\/labinvest.2009.144","type":"journal-article","created":{"date-parts":[[2010,1,18]],"date-time":"2010-01-18T10:33:44Z","timestamp":1263810824000},"page":"402-413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Fas receptor is required for estrogen deficiency-induced bone loss in mice"],"prefix":"10.1016","volume":"90","author":[{"given":"Natasa","family":"Kovacic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danka","family":"Grcevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vedran","family":"Katavic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan Kresimir","family":"Lukic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Grubisic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlo","family":"Mihovilovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hrvoje","family":"Cvija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Ian","family":"Croucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Marusic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/labinvest.2009.144_bib1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.1621100","article-title":"Increased osteoclast development after estrogen loss: mediation by interleukin-6","volume":"257","author":"Jilka","year":"1992","journal-title":"Science"},{"key":"10.1038\/labinvest.2009.144_bib2","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1074935","article-title":"Reversal of bone loss in mice by nongenotropic signaling of sex steroids","volume":"298","author":"Kousteni","year":"2002","journal-title":"Science"},{"key":"10.1038\/labinvest.2009.144_bib3","first-page":"3128","article-title":"The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone","volume":"82","author":"Tomkinson","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/labinvest.2009.144_bib4","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1021\/cr010183n","article-title":"Caspases: keys in the ignition of cell death","volume":"102","author":"Denault","year":"2002","journal-title":"Chem Rev"},{"key":"10.1038\/labinvest.2009.144_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2567.2005.02143.x","article-title":"The intriguing biology of the tumour necrosis factor\/tumour necrosis factor receptor superfamily: players, rules and the games","volume":"115","author":"Hehlgans","year":"2005","journal-title":"Immunology"},{"key":"10.1038\/labinvest.2009.144_bib6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/82712","article-title":"The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity","volume":"1","author":"Siegel","year":"2000","journal-title":"Nat Immunol"},{"key":"10.1038\/labinvest.2009.144_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0002-9440(10)65111-5","article-title":"Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjogren\u2019s syndrome through fas-mediated apoptosis","volume":"155","author":"Ishimaru","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1038\/labinvest.2009.144_bib8","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1210\/en.2005-0279","article-title":"Estrogens up-regulate the Fas\/FasL apoptotic pathway in lactotropes","volume":"146","author":"Jaita","year":"2005","journal-title":"Endocrinology"},{"key":"10.1038\/labinvest.2009.144_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/j.1460-2075.1996.tb00351.x","article-title":"Involvement of Fas in regression of vaginal epithelia after ovariectomy and during an estrous cycle","volume":"15","author":"Suzuki","year":"1996","journal-title":"EMBO J"},{"key":"10.1038\/labinvest.2009.144_bib10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.bone.2004.02.021","article-title":"Modulation of survival in osteoblasts from postmenopausal women","volume":"35","author":"Garcia-Moreno","year":"2004","journal-title":"Bone"},{"key":"10.1038\/labinvest.2009.144_bib11","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.4049\/jimmunol.178.6.3379","article-title":"The Fas\/Fas ligand system inhibits differentiation of murine osteoblasts but has a limited role in osteoblast and osteoclast apoptosis","volume":"178","author":"Kovacic","year":"2007","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.2009.144_bib12","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/ng1195-294","article-title":"Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver","volume":"11","author":"Adachi","year":"1995","journal-title":"Nat Genet"},{"key":"10.1038\/labinvest.2009.144_bib13","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.4049\/jimmunol.170.3.1540","article-title":"Increased bone mass is a part of the generalized lymphoproliferative disorder phenotype in the mouse","volume":"170","author":"Katavic","year":"2003","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.2009.144_bib14","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.4049\/jimmunol.165.8.4231","article-title":"Depletion of CD4 and CD8 T lymphocytes in mice in vivo enhances 1,25-dihydroxyvitamin D3-stimulated osteoclast-like cell formation in vitro by a mechanism that is dependent on prostaglandin synthesis","volume":"165","author":"Grcevic","year":"2000","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.2009.144_bib15","series-title":"1st European Conference in Functional Genomics and Diseases","article-title":"Advanced quantitative real-time PCR in clinical diagnostics and cDNA microarray validation","author":"Stahlberg","year":"2003"},{"key":"10.1038\/labinvest.2009.144_bib16","unstructured":"University of Connecticut Health Center. Genome anatomy project for the osteoprogenitor lineage. Available from: http:\/\/skeletalbiology.uchc.edu\/30_ResearchProgram\/304_gap\/index.htm."},{"key":"10.1038\/labinvest.2009.144_bib17","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.bone.2003.07.006","article-title":"Expression and function of TNF-family proteins and receptors in human osteoblasts","volume":"33","author":"Bu","year":"2003","journal-title":"Bone"},{"key":"10.1038\/labinvest.2009.144_bib18","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s002230010069","article-title":"The immunohistochemical localization of Fas and Fas ligand in jaw bone and tooth germ of human fetuses","volume":"66","author":"Hatakeyama","year":"2000","journal-title":"Calcif Tissue Int"},{"key":"10.1038\/labinvest.2009.144_bib19","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1002\/art.11322","article-title":"Suppression of osteoclastogenesis in rheumatoid arthritis by induction of apoptosis in activated CD4+ T cells","volume":"48","author":"Ogawa","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1038\/labinvest.2009.144_bib20","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1210\/en.2003-0296","article-title":"Osteoclast apoptosis: the role of Fas in vivoin vitro","volume":"144","author":"Wu","year":"2003","journal-title":"Endocrinology"},{"key":"10.1038\/labinvest.2009.144_bib21","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1126\/science.7533326","article-title":"The Fas death factor","volume":"267","author":"Nagata","year":"1995","journal-title":"Science"},{"key":"10.1038\/labinvest.2009.144_bib22","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.4049\/jimmunol.156.8.2693","article-title":"Fc receptor-induced expression of Fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis","volume":"156","author":"Eischen","year":"1996","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.2009.144_bib23","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.4049\/jimmunol.159.4.1594","article-title":"Human monocytic cells contain high levels of intracellular Fas ligand: rapid release following cellular activation","volume":"159","author":"Kiener","year":"1997","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.2009.144_bib24","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1182\/blood.V93.3.796","article-title":"Apoptotic role of Fas\/Fas ligand system in the regulation of erythropoiesis","volume":"93","author":"De Maria","year":"1999","journal-title":"Blood"},{"key":"10.1038\/labinvest.2009.144_bib25","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/sj.emboj.7601984","article-title":"Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival","volume":"27","author":"Krum","year":"2008","journal-title":"EMBO J"},{"key":"10.1038\/labinvest.2009.144_bib26","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2007.07.025","article-title":"Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts","volume":"130","author":"Nakamura","year":"2007","journal-title":"Cell"},{"key":"10.1038\/labinvest.2009.144_bib27","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1084\/jem.186.4.489","article-title":"Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts","volume":"186","author":"Kameda","year":"1997","journal-title":"J Exp Med"},{"key":"10.1038\/labinvest.2009.144_bib28","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1172\/JCI11066","article-title":"Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha","volume":"106","author":"Cenci","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1038\/labinvest.2009.144_bib29","doi-asserted-by":"crossref","first-page":"7193","DOI":"10.4049\/jimmunol.175.11.7193","article-title":"Interaction of Fas ligand and Fas expressed on osteoclast precursors increases osteoclastogenesis","volume":"175","author":"Park","year":"2005","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.2009.144_bib30","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1172\/JCI1039","article-title":"Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow. Evidence for autonomy from factors released during bone resorption","volume":"101","author":"Jilka","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1038\/labinvest.2009.144_bib31","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1359\/jbmr.1997.12.10.1637","article-title":"Fas and Fas ligand interaction is necessary for human osteoblast apoptosis","volume":"12","author":"Kawakami","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1038\/labinvest.2009.144_bib32","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0022-2143(99)90201-9","article-title":"Tumor necrosis factor-alpha and interleukin-1beta increase the Fas-mediated apoptosis of human osteoblasts","volume":"134","author":"Tsuboi","year":"1999","journal-title":"J Lab Clin Med"},{"key":"10.1038\/labinvest.2009.144_bib33","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.lfs.2005.05.026","article-title":"Myricetin inhibits the induction of anti-Fas IgM-, tumor necrosis factor-alpha- and interleukin-1beta-mediated apoptosis by Fas pathway inhibition in human osteoblastic cell line MG-63","volume":"77","author":"Kuo","year":"2005","journal-title":"Life Sci"},{"key":"10.1038\/labinvest.2009.144_bib34","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.intimp.2006.02.010","article-title":"Fraxetin inhibits the induction of anti-Fas IgM, tumor necrosis factor-alpha and interleukin-1beta-mediated apoptosis by Fas pathway inhibition in human osteoblastic cell line MG-63","volume":"6","author":"Kuo","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"10.1038\/labinvest.2009.144_bib35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/toxsci\/70.1.63","article-title":"Role of death receptor pathway in estradiol-induced T-cell apoptosis in vivo","volume":"70","author":"Do","year":"2002","journal-title":"Toxicol Sci"},{"key":"10.1038\/labinvest.2009.144_bib36","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.bbrc.2004.11.097","article-title":"Mechanisms of sex steroid effects on bone","volume":"328","author":"Syed","year":"2005","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/labinvest2009144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest2009144","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722025223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722025223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest2009144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:49:48Z","timestamp":1758397788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722025223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0023683722025223"],"URL":"https:\/\/doi.org\/10.1038\/labinvest.2009.144","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fas receptor is required for estrogen deficiency-induced bone loss in mice","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.2009.144","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.2010.41","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2010 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}